These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 8602631

  • 1. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.
    Rick ME, Krizek DM.
    Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631
    [Abstract] [Full Text] [Related]

  • 2. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M.
    Acta Haematol; 2009 Apr; 121(2-3):102-5. PubMed ID: 19506355
    [Abstract] [Full Text] [Related]

  • 3. Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan.
    Nishino M, Miura S, Yoshioka A, Kuwahara I, Nishimura T, Hamada K, Fukui H.
    Int J Hematol; 1993 Apr; 57(2):163-73. PubMed ID: 8494994
    [Abstract] [Full Text] [Related]

  • 4. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
    Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z.
    Acta Haematol; 2009 Apr; 121(2-3):119-27. PubMed ID: 19506358
    [Abstract] [Full Text] [Related]

  • 5. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z.
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [Abstract] [Full Text] [Related]

  • 6. Functional analysis of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression.
    Lavergne JM, Piao Y, Ribba AS, Girma JP, Siguret V, Piétu G, Boyer-Neumann C, Schandelong A, Bahnak BR, Meyer D.
    Thromb Haemost; 1993 Oct 18; 70(4):691-6. PubMed ID: 8115998
    [Abstract] [Full Text] [Related]

  • 7. Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130F.
    Castaman G, Eikenboom JC, Contri A, Rodeghiero F.
    Thromb Haemost; 2000 Aug 18; 84(2):351-2. PubMed ID: 10959713
    [No Abstract] [Full Text] [Related]

  • 8. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations.
    Nesbitt IM, Hampton KK, Preston FE, Peake IR, Goodeve AC.
    Thromb Haemost; 1999 Sep 18; 82(3):1061-4. PubMed ID: 10494764
    [Abstract] [Full Text] [Related]

  • 9. [Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].
    Batlle J, Blanco-López MJ, Castiñeira MP, López-Fernández MF.
    Sangre (Barc); 1992 Jun 18; 37(3):211-24. PubMed ID: 1359656
    [No Abstract] [Full Text] [Related]

  • 10. Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor.
    Donnér M, Kristoffersson AC, Berntorp E, Scheibel E, Thorsen S, Dahlbäck B, Nilsson IM, Holmberg L.
    Eur J Haematol; 1993 Jul 18; 51(1):38-44. PubMed ID: 8348943
    [Abstract] [Full Text] [Related]

  • 11. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A, Berneman Z, Schroyens W, Michiels JJ.
    Acta Haematol; 2009 Jul 18; 121(2-3):128-38. PubMed ID: 19506359
    [Abstract] [Full Text] [Related]

  • 12. Molecular genetics of von Willebrand disease.
    Mazurier C, Ribba AS, Gaucher C, Meyer D.
    Ann Genet; 1998 Jul 18; 41(1):34-43. PubMed ID: 9599650
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
    Casonato A, Pontara E, Boscaro M, Dannhauser D, Sartori MT, Girolami A.
    Haematologia (Budap); 1993 Jul 18; 25(1):57-67. PubMed ID: 8339998
    [Abstract] [Full Text] [Related]

  • 15. [Variant type von Willebrand disease with defective binding to factor VIII].
    Shima M.
    Ryoikibetsu Shokogun Shirizu; 1998 Jul 18; (21 Pt 2):430-3. PubMed ID: 9833534
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan 18; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Mutation (Ala737-->Glu) in type 2A von Willebrand disease].
    Wang Y, Zhang J, Wan H.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar 18; 20(3):117-9. PubMed ID: 11601234
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.